Nortech Systems Incorporated Common Stock (NSYS)

FairStock Score: 57/100 — STEADY

Key Financials

Strengths

• Generates $4 million in annual free cash flow (8.9% yield on market cap)
• Strong Piotroski F-Score of 9/9 indicating robust financial health across profitability, leverage, and efficiency metrics

Concerns

• No meaningful dividend despite modest growth—total return depends entirely on multiple expansion

AI Analysis

Nortech Systems Incorporated Common Stock is a micro-cap healthcare company valued at $42 million. Revenue stands at $122 million. From a quality standpoint, Nortech shows near-perfect Piotroski F-Score of 9/9 indicating exceptional financial health and Altman Z-Score of 1.9 in the grey zone. On valuation, the stock is trading at a premium 32.7x earnings, with trades above its Graham Number with a negative 45% margin. Growth dynamics show revenue growing at 5.9% and profit growth of 160.7%. Our composite FairStock Score of 57/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $4 million in annual free cash flow (8.9% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

At 33x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer